# Antipsychotic Induced Structural and Functional Brain Changes

> **NCT02435095** · PHASE4 · TERMINATED · sponsor: **RWTH Aachen University** · enrollment: 174 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Maintenance treatment
- **DRUG:** Intermittent treatment

## Key facts

- **NCT ID:** NCT02435095
- **Lead sponsor:** RWTH Aachen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 174 (ACTUAL)
- **Why stopped:** slow patient recruitment, low patient-commpliance, high dropout rates,
- **Last updated:** 2020-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02435095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02435095, "Antipsychotic Induced Structural and Functional Brain Changes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02435095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*